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ABSTRACT 
Objective: Fenofibrate, a hypolipidemic drug agent, exhibits poor water solubility and dissolution. Thus, the aim of the present study was to 
improve the solubility and dissolution rate of Fenofibrate by preparing microspheres by spray drying technique using Pluronic F-127.  
Methods: Fenofibrate Microspheres containing different ratios of Pluronic F-127 were produced by spray drying using Chloroform as solvent to 
enhance solubility and dissolution rate. The prepared formulations containing different ratios of drug and Pluronic F-127were evaluated for 
solubility and in-vitro dissolution. The prepared formulations were characterized by DSC, FT-IR, XRD and SEM. Dissolution profile of the prepared 
spray dried microspheres was compared with its physical mixture and the pure sample.  
Results: Spray dried microspheres exhibited decreased crystallinity. The solubility of microspheres containing Fenofibrate and Pluronic F-
127(1:3w/w) exhibited three tenfold increases than the commercial Fenofibrate and dissolution of the same ratio microsphere showed 99 % 
release in 40 min. While same composition in physical mixture showed 37% release in 20 min.  
Conclusion: Consequently, from the above result it can be concluded that spray dried microspheres of Fenofibrate is a useful technique to improve 
the solubility and dissolution of poor water soluble drug like Fenofibrate. 
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INTRODUCTION 
Fenofibrate has been used for many years to lower cholesterol levels 
and its pharmacokinetics profile is well understood [1, 2]. Originally 
launched in 1975, it is currently on the market in more than 85 
countries. The compound is practically insoluble in water and has 
high lipophilicity (log P = 5.24). Thus, the dissolution rate of 
fenofibrate is expected to limit its absorption from the 
gastrointestinal tract. Attempts to increase the oral bioavailability of 
the drug have therefore chiefly centered on particle size reduction. 
Increasing the rate and extent of dissolution of Fenofibrate by 
micronization has been shown to lead directly to an increased oral 
bioavailability, which in turn enables dosage reduction. Recently, 
‘‘suprabioavailable’’ tablets have been developed combining the 
classic micronization process with a specific micro coating 
technology, through which micronized drug particles are coated 
onto hydrophilic polyvinylpyrrolidone (PVP) cores [3]. 
Consideration of the modified Noyes-Whitney equation provides 
some hints as to how the dissolution rate of very poorly soluble 
compounds might be improved to minimize the limitations to their 
oral availability. There have been numerous efforts to improve drug 
dissolution rates. These include (a) reducing the particle size to 
increase the surface area; (b) using water-soluble carriers to form 
inclusion complexes; (c) solubilization in surfactant systems; (d) 
using pro-drugs and drug derivatization; and (e) manipulation of the 
solid state of drug substances to improve the drug dissolution i. e. by 
reducing the crystallinity of drug substances through formation of 
solid dispersions. However, there are practical limitations to these 
techniques [4]. Although particle size reduction is commonly used to 
increase the dissolution rate, there is a practical limit to the size 
reduction that can be achieved by such commonly used methods as 
controlled crystallization and grinding. The use of very fine powders 
in a dosage form may also be problematic because of handling 
difficulties and poor wettability. Salt formation is not feasible for 
neutral compounds and the synthesis of appropriate salt forms of 
drugs which are weakly acidic or weakly basic may often not be 
practical. Even when salts can be prepared, an increased dissolution 
rate in the gastrointestinal tract may not be achieved in many cases 
because of the reconversion of salts into aggregates of their 
respective acid or base forms. The solubilization of drugs in organic 
solvents or in aqueous media by the use of surfactants and co-
solvents leads to liquid formation that is usually undesirable from 
the viewpoints of patient acceptability and marketing [5]. Solid 
dispersions have been widely used to enhance the solubility, 
dissolution rate, and bioavailability of poorly soluble drugs [6, 7, 8, 
9]. There are different types solid dispersion systems categorized 
according to the physical states of the drug and the carrier in the 
systems. It may be a molecular solid solution, a dispersion of 
amorphous or crystalline drug particles in an amorphous carrier 
matrix, or a combination of solution and dispersion of solids.  
The enhancement in the dissolution rate is obtained by one or a 
combination of the following mechanisms: eutectic formation, 
increased surface area of the drug due to precipitation in the carrier, 
formation of true solid solution, improved wettability and drug 
precipitation as a meta stable crystalline form or a decrease in 
substance crystallinity. The type of solid dispersion formed depends 
on both the carrier-drug combination and the method of 
manufacture. Spray drying is one of the techniques of preparing 
solid dispersion and is widely used as an alternative to milling to 
reduce particle size [10-13]. The large surface area of the resulting 
particle should result in an enhanced solubility and dissolution rate, 
consequently, improved bioavailability.  
The aim of the present study was to improve the solubility and 
dissolution rate of fenofibrate by spray drying technique using 
different ratio of Pluronic F-127.  
MATERIALS AND METHODS 
Materials 
All chemicals and buffers used were of analytical grade. 
Methods 
Preparation of microspheres  
The microspheres were prepared by spray-drying technique. The 
spray drying was performed by Mini Spray Dryer LSD -48; (Jay 
Instrument & systems Pvt. Ltd. Mumbai). The different drug–
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 7, Issue 1, 2015 
Innovare 
Academic Sciences 
Dixit et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 1, 173-177 
 
174 
polymer ratios used for various microsphere formulations were 
prepared described in Table 1. The polymer solution was prepared 
by adding the given quantity of polymer to the Acetone as solvent. 
The given quantity of Fenofibrate was added to the polymer solution 
and the resulting mixture was spray-dried. The spray drying 
parameters is described in table 2. 
 
Table 1: Spray-Dried microspheres formulation 
Numbers Formulation Code Different ratio of polymer and drug (w/w) 
Spray drying formulations 
1 SD 1 1:1 
2 SD 2 1:2 
3 SD 3 1:3 
Physical mixture 
1 PM 1 1:1 
2 PM 2 1:2 
3 PM 3 1:3 
 
Table 2: Spray-Drying Parameters 
Inlet temperature 
(°C) 
Feed pump speed % Vacuum 
(mm Wc) 
Aspirator level (kg/cm2) 
52 10 -70 1.5 
 
Preparation of physical mixtures 
The different drug–polymer ratios used for various physical 
mixtures formulations were prepared as described in Table 1 and 
were prepared by mixing different ratio of Fenofibrate and Pluronic 
F-127 in the mortar for 5 min and then sieving. 
Evaluation of microspheres 
Determination of percentage yield and drug content 
The percentage yield of each formulation was determined according 
to the total recoverable final weight of microspheres and the total 
original weight of Fenofibrate and Pluronic F-127.  
Microspheres (50 mg) were triturated with 10 ml of water. Allowed 
to stand for 10 min with occasional swirling and methanol was 
added to produce 100 ml. After suitable dilution, samples were 
measured at 250 nm. Drug content was determined from the 
standard plot. 
Differential scanning calorimetry (DSC) 
A DSC study was carried out to detect possible polymorphic 
transition during the crystallization process. DSC measurements 
were performed on a DSC DuPont 9900, differential scanning 
calorimeter with a thermal analyzer.  
Fourier transform infrared spectroscopy (FTIR) 
The FTIR spectral measurements were taken at ambient 
temperature using a Shimadzu, Model 8033 (USA). Samples were 
dispersed in KBr powder and the pellets were made by applying 5 
ton pressure. FTIR spectra were obtained by powder diffuse 
reflectance on FTIR spectrophotometer. 
X-ray diffraction analysis (XRD) 
X-Ray powder diffraction patterns were obtained at room 
temperature using a Philips X’ Pert MPD diffractometer, with Cu as 
anode material and graphite monochromator, operated at a voltage 
of 40 mA, 45 kV. The process parameters used were set as scan step 
size of 0.0170 (2θ). 
Scanning electron microscopy (SEM) 
Scanning electron microscopic (Joel- LV-5600, USA, with 
magnification of 250x) photographs was obtained to identify and 
confirm spherical nature and surface topography of the crystals. 
Mechanical properties 
Tensile strength of microspheres was determined by compressing 
500 mg of crystals using hydraulic press at different ton/cm2 for 1 
min. The compacts were stored in desicator overnight to allow 
elastic recovery. The thickness and diameter were measured for 
each compact. The hardness of each compact was then measured 
using Pfizer hardness tester. The tensile strength (σ) of the Compact 
(ton/cm2
σ = 2F/π Dt 
) was calculated using following equation. 
Where, F, D and t are hardness (ton), compact diameter (cm) and 
thickness (cm), respectively. 
Determination of solubility 
Drug solubility was determined by adding excess amounts of pure 
Fenofibrate, their physical mixture and microspheres in distilled 
water at 37 ± 0.5°C, respectively. The solution formed were 
equilibrated under continuous agitation for 24 h and passed through 
a 0.8 μm membrane filter to obtain a clear solution. The absorbance 
of the samples was measured using UV spectrophotometer method 
(UV 1601 A Shimadzu, Japan) at 290 nm and the concentrations in 
μg/ml were determined. Each sample was determined in triplicate. 
Dissolution studies of microspheres 
The dissolution of pure Fenofibrate, their physical mixture and 
microspheres was determined by using USP dissolution apparatus XXIV-
Type II (Electro Lab, Mumbai). Dissolution medium was 900 ml of pH 7.4 
phosphate buffers. The amount of dissolved drug was determined using 
UV spectrophotometer method (UV 1601 A Shimadzu, Japan) at 290 nm. 
Each sample was determined in triplicate.  
Determination of the physical stability 
To determine the physical stability of optimized Microspheres, a 
stability study of prepared Microspheres was carried out at 25°C 
and 60% relative humidity for 6 months according to the ICH 
guidelines. The spherical agglomerates were packed in high density 
polyethylene (HDPE) container and placed in the stability chamber. 
The samples were withdrawn at the interval of 0, 1, 3 and 6 months 
and evaluated for appearance, characterization by FT-IR and 
dissolution release and compared with initial results. 
RESULT AND DISCUSSION 
The spray dried microspheres formulations were collected and was 
found to be free-flowing and white in color. The percentage yield of 
spray dried microspheres of different ratios of drug–polymer was 
found to be in the range of 74-87 %. This small yield could be 
increased by addition of solid substance or in large scale production 
[14]. Drug content for the spray dried microspheres of different 
ratio of drug–polymer formulation was found to be in the range of 
97-99 %±0.03 (Table-3). 
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DSC curves obtained for pure material, physical mixtures and 
microspheres are showed Fig. 1. In DSC curve, pure Fenofibrate had 
a sharp endothermic peak at 81.5°C that corresponded to the 
melting point of Fenofibrate. While Microspheres and physical 
mixture exhibit endothermic peaks at 80.12°C and 54.16°C 
respectively. Reduction in intensity and shifting of sharp melting 
peak of drug in solid dispersion indicates that the degree of 
crystallinity is considerably reduced and the drug is present in an 
amorphous form.  
 
 
Fig. 1: DSC Spectrum of pure drug, physical mixture and 
microspheres 
 
The FTIR spectra of pure Fenofibrate, Pluronic F-127, their physical 
mixture and microspheres are shown in fig. 2. FTIR spectroscopy 
has been successfully used for exploring the differences in molecular 
conformations, crystal packing and hydrogen bonding arrangements 
for different solid-state forms of an organic compound. Spectral 
variations originate due to alteration in bonds that exhibit 
characteristic vibration frequencies, leading to frequency shifts and 
splitting in absorption peaks. The FT-IR spectrum of pure drug (Fig. 
2) shows characteristic peaks at 3039 cm-1 due to alkyl groups, at 
3439 cm-1 due to phenol and at 1625 cm-1 due to carbonyl group. 
FT-IR spectra of Physical mixture and Microspheres showed 
broadening of the peak at 1100 cm-1 which may be due to Pluronic 
F-127. Hence we can say that significant interaction between drug 
and carrier has taken place. Also the peaks of Fenofibrate in the 
region of 2000 cm-1 to 400 cm-1 have disappeared in Microspheres 




Fig. 2: FT-IR Spectrum of pure drug, physical mixture (1:3) and 
microspheres (1:3) 
 
X- Ray diffraction was used to analyze potential changes in the inner 
structure of Fenofibrate nano crystals during the formulation of the 
Microspheres. The extent of such changes depends on the chemical 
nature and physical hardness of the active ingredient. The powder X-
ray dif-fraction patterns of the pure drug, PM, and Microspheres are 
shown in fig. 2. The results of the DSC were further confirmed by X-
ray diffraction studies (fig. 3). The characteristic peak of the 
Fenofibrate appeared in the 2θ range of 10–40o
The X-ray diffraction study of the drug and excipients PM showed 
the peak corresponding to the crystalline drug molecules present in 
the mixture, although their intensity was lower due to the high 
excipients-drug ratio employed. The diffraction pattern of the drug 
Microspheres showed absence, broadening and reduction of major 
Fenofibrate diffraction peaks, thus indicating that the Microspheres 
contained mostly an amorphous form (disordered state). These 
results could explain the observed enhancement of solubility and 
rapid dissolution of Fenofibrate in Microspheres. 
, The X-Ray 
diffraction pattern for Fenofibrate and Microspheres are presented 
in Fig.3 and showed marked crystallinity as evident from the sharp 
peaks at 2θ angles of 24.5°, 25.9° and 27.6°. The degree of 
crystallinity is seen to be decreased and it depends on the 
processing method. The XRPD of spray dried Microspheres shows 
further decrease in the degree of crystallinity as evident from the 
disappearance of the sharp peaks. The reason for this could be that 
spray drying is an energy intensive process where solution passes 
from state of relative unsaturation to supersaturation in a fraction of 
seconds. Further rapid evaporation of solvent from the 
supersaturated atomized droplets of the solution seemingly 
interferes with the crystal building process leading to amorphization 
of the drug.  
 
 
Fig. 3: X- Ray diffractogram of pure drug, physical mixture and 
microspheres 
 
The SEM image of the pure drug, physical mixture and microspheres 
are shown in Fig. 4. The Fenofibrate particles in the physical mixture 
were broken into much smaller ones and irregular size (12-19 µm) 
and the shape of prepared microspheres are uniform and spherical 
in shape with small in size (4-13 µm) (Table-3).  
The spherical shape of microspheres does not lead to cake formation 
during storage because of less point of contact thereby increasing 
the stability of the microsphere formulation, which is an advantage 
over other shapes. This could be therefore, indicate that Fenofibrate 




Fig. 4: SEM of pure drug, physical mixture and microspheres 
 
Microspheres exhibited superior compressibility characteristics 
compared to physical mixture and pure sample of Fenofibrate drug 
crystals (Fig. 5). It could be due to the fact that during the process of 
compression fresh surfaces are formed by fracturing crystals. 
Surface freshly prepared by fracture enhanced the plastic 
interparticle bonding, resulting in a lower compression force 
required for compressing the microspheres under plastic 
deformation compared to that of single crystal. Tensile strength of 
the same ratio of microspheres and physical mixture (1:3) showed 
that tensile strength of microspheres higher than physical mixture 
as well as the pure sample. This could be due to the increasing in the 
plastic interparticle bonding of microspheres [15, 16]. 
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Fig. 5: Tensile strength of pure drug, physical mixture (1:3) and 
microspheres (1:3) 
Increase in the solubility of Fenofibrate from microspheres (15.4 
µg/mL) was found to be nearly three times higher than the solubility 
of the pure drug (5.2 µg/mL), suggesting the presence of a high 
amount of an amorphous form of Fenofibrate in the Microspheres, 
indicating super-saturation obtained from the Microspheres. 
Increase in the solubility of Fenofibrate from the PM (10.1 µg/mL) 
was nearly two times higher than pure drug. This could be due to the 
solubilising effect of highly water-soluble Pluronic F-127 used in the 
formulation. The solubility results for the different formulations are 
shown in table 3. The higher solubility of Fenofibrate from 
Microspheres may be due to the increased surface area, wettability 
and solubilising effect of highly water-soluble Pluronic F-127 used in 
the formulations. 
 
Table 3: Solubility, Percentage yield, Drug content and Particle size microspheres 
Formulations code polymer: 
Drug ratio(w/w) 
Concentration of Fenofibrate 




Drug content SD ±3 Particle size 
determination (μm) 
SD±3 
Pure drug 5.2 -- -- -- 
SD 1 6.4 74.85 98.51±0.02 4-13 
SD 2 11.7 79.64 98.94±0.03 7-12 
SD 3 15.4 87.13 99.64±-0.01 5-13 
PM 1 5.8 - 97.78±0.02 12-19 
PM 2 7.5 - 97.34±0.04 15-19 
PM 3 9.4 - 98.53±0.02 12-18 
 
The dissolution of pure Fenofibrate, physical mixture and prepared 
microspheres in pH 7.4 phosphate buffer shown in Fig. 6, the 
dissolution profiles were plotted as the % release from the different 
microspheres, physical mixture and pure Fenofibrate versus time in 
minute. The rate of dissolution of pure Fenofibrate was slow 
compared with Fenofibrate from its physical mixtures and different 
microspheres formulation in 60 min.  
 
 
Fig. 6: Dissolution release of pure drug, physical mixture and 
microspheres 
The % release from ratio of (1:3 w/w) drug and polymer showed 
more release compared to other ratios. In case of microspheres 
containing (1:3 w/w) showed 99% release in 40 min and at the 
same ratio of physical mixture showed 72% release in 60 min. 
There was a significant difference in the drug release between the 
microspheres and physical mixture. The increase in dissolution from 
the microspheres and physical mixtures was probably due to the 
wetting and solubilizing effect of the Pluronic F-127, which could 
reduce the interfacial tension between the Fenofibrate and the 
dissolution medium, thus leading to a higher dissolution rate than 
pure Fenofibrate. The large surface area of the resulting 
microspheres should result in an enhanced dissolution rate and 
thereby improve the bioavailability. 
The best way to guarantee stability is by maintaining their physical 
state and molecular structure. The results of the stability study of 
prepared microspheres (1:3 w/w) of Fenofibrate stored at 25 0
  
C and 
60% relative humidity for 6 month are presented in Table 4. The 
influence of physical stability on the prepared crystals was 
investigated. Prepared microspheres of Fenofibrate were stable and 
complied with all the properties when compared to initial results of 
prepared microspheres of Fenofibrate. 
Table 4: Stability data of Spray dried microspheres 




Sample name: Fenofibrate microspheres (1:3 w/w) 
Storage condition: 250C /60% RH 
Initial White to off white As standard  As standard 99.64±0.01 99.60±0.011 
1 month Complies Complies Complies 99.28±0.02 98.39±0.040 
3 month Complies Complies Complies 99.14±0.01 99.28±0.027 
6 month Complies Complies Complies 99.87±0.03 99.89±0.013 
 
CONCLUSION 
In this present study, an increased solubility and dissolution rate of 
Fenofibrate were achieved by preparing microspheres by spray 
drying technique using different ratio of Pluronic F-127. DSC, FT-IR 
and XRD studies showed that there is no change in the crystal 
structure of Fenofibrate during the spray drying process and 
showed that spray dried microspheres exhibited decreased 
crystallinity. The solubility and dissolution of the spray dried 
microspheres was improved significantly compared with its physical 
mixture and pure sample of Fenofibrate. The Fenofibrate 
microspheres containing 1:3 w/w (Fenofibrate: Pluronic F-127) 
showed highest % of drug release and solubility compare to other 
ratio, physical mixture and pure sample of Fenofibrate. Stability 
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results showed that prepared microspheres stable for 6 month as 
per ICH guidelines. Hence,, from the above result it can be concluded 
that spray dried microspheres of Fenofibrate is a useful technique to 
improve the solubility and dissolution of poorly water soluble drug 
like Fenofibrate. 
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